Garner Ebun 4
4 · Erasca, Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
Erasca (ERAS) CLO Garner Ebun Exercises Options, Sells Shares
What Happened Garner Ebun, Chief Legal Officer of Erasca, exercised 80,000 stock options at $1.70 per share (cost $136,000) and immediately sold 80,000 shares in the open market for a weighted-average price of $16.40 per share (gross proceeds $1,312,000). The transactions were reported on Form 4 filed April 3, 2026, covering activity on April 1, 2026. A separate Form 4 line shows a related derivative conversion reported at $0.00, which is part of the exercise/settlement mechanics.
Key Details
- Transaction date: April 1, 2026; Form 4 filed April 3, 2026 (timely).
- Option exercise: 80,000 shares exercised @ $1.70 = $136,000 cash cost.
- Sale: 80,000 shares sold in multiple trades; weighted-average sale price $16.40; gross proceeds $1,312,000 (individual sale prices ranged $16.11–$16.58).
- Net proceeds before taxes/fees ≈ $1.176M (gross proceeds minus exercise cost).
- Footnote F1: Sales effected under a Rule 10b5-1 trading plan adopted June 30, 2024.
- Footnote F3: Options vest 1/48th monthly beginning Feb 1, 2024 (vesting contingent on continued service).
- Shares owned after the transaction are not disclosed in this filing.
- The $0.00 derivative disposition line reflects conversion/settlement related to the option exercise.
Context This was effectively an exercise-and-sell (often called a cashless exercise) executed under a pre-established 10b5-1 plan, which typically means the sale was pre-arranged and not an ad hoc market-timing decision. Such planned sales are routine for insiders converting option value to cash; they should not be taken alone as a signal of company outlook.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-04-01$1.70/sh+80,000$136,000→ 105,076 total - Sale
Common Stock
[F1][F2]2026-04-01$16.40/sh−80,000$1,312,000→ 25,076 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F3]2026-04-01−80,000→ 280,000 totalExercise: $1.70Exp: 2034-02-04→ Common Stock (80,000 underlying)
Footnotes (3)
- [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.58. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.